In an article published on April 28 in Nature, researchers from Yale University have identified a specific immune response that leads to severe cases of COVID-19 and even death. Scientists have shown that monocytes infected with Novel Coronavirus can trigger cytokine storms, triggering a massive inf......

Case reports and surveillance data from the United States, Israel, and Canada suggest an increased risk of myocarditis after vaccination with sarS-COV-2 mRNA vaccine, higher after the second dose, with a stronger association among young men. Data from Canada and France indicate that more cases of my......

On April 11, BioNTech announced an exclusive partnership with Matinas BioPharma to combine BioNTech's mRNA vaccine development expertise with Matinas' Lipid Nanocrystal (LNC) delivery platform technology, Advance the development of new dosage forms for mRNA vaccines, including a potential preparatio......

With the continuous improvement of the degree of specialization of pharmaceutical outsourcing service institutions, the content of pharmaceutical outsourcing service gradually covers every link from disease target research, drug compound screening, clinical trial service, process research and develo......

Obicetrapib is an adjunct to dietary and maximum tolerated dose lipid-lowering therapy, according to an announcement on the official website of the Drug Evaluation Center (CDE) of the State Food and Drug Administration of China on March 23. For the treatment of adult patients with familial heterozyg......

Remoxiumab is the first and to date the only second-line therapy approved for gastric/gastroesophageal junction cancer in the world.